No Detail Found!

Pre-treatment Delta Neutrophil Index as a Predictive Factor in Renal Cell Carcinoma

Author(s)
Osman Barut Department of Urology, Faculty of Medicine, Sutcu Imam University,Turkey
Mehmet Kutlu Demirkol Department of Urology, Faculty of Medicine, Sutcu Imam University,Turkey
Faruk Kucukdurmaz Department of Urology, Faculty of Medicine, Sutcu Imam University,Turkey
Tayfun Sahinkanat Department of Urology, Faculty of Medicine, Sutcu Imam University,Turkey
Sefa Resim Department of Urology, Faculty of Medicine, Sutcu Imam University,Turkey
Abstract
Objective: To determine the diagnostic value of the pre-treatment delta neutrophil index (DNI) before treatment in patients with renal cell carcinoma (RCC) and to compare this marker with other routine in ammation markers, such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR). Study Design: Descriptive study. Place and Duration of Study: Department of Urology, Kahramanmaras Sutcu Imam University, Turkey, from February 2017 to January 2020. Methodology: Data of patients who underwent radical nephrectomy for RCC, were evaluated.For comparison, healthy individuals were included in the study as a control group. Demographic data, such as age, gender, routine laboratory tests, DNI, NLR, and PLR levels of the groups were recorded and compared. Results: There were 73 patients in the RCC group and 71 healthy individuals in the control group. DNI, NLR and PLR levels were signi cantly higher in the RCC group (p <0.001, eacDhN).I and NLR were signi cantly higher in patients with advanced stage (T3-T4) and high grade (G3-G4).In univariate logistic regression analysis hemoglobin (p=0.023), neutrophil (p<0.001), lymphocyte (p=0.009), platelet (p<0.001), DNI (p<0.001), NLR (p<0.001) and PLR (p<0.001) were identi ed as predictors for RCC. In multivariate logistic regression analysis, DNI and NLR (p<0.001, each) were found to be the predictors of RCC. Cut-o values were 0.45% for DNI, 1.80 for NLR, and 130.09 for PLR. Conclusion: DNI is a new in ammatory marker, which is included in complete blood count parameters; and does not require any additional calculation, unlike NLR and PLR. It can be used in the prediction of RCC.
Publication Details
Page(s) 156-161
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
Renal Cell Carcinoma, Neutrophil-lymphocyte ratio, Platelet-lymphocyte ratio, Delta neutrophil index
0

Citations

0

Downloads

66

Views